Early cardiovascular remodelling in Fabry disease-Reference-Cited by-同舟云学术

Early cardiovascular remodelling in Fabry disease

Published:2013-04-25 Issue:1 Volume:37 Page:109-116
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:J Inherit Metab Dis

Author:

Costanzo Luca,Buccheri Sergio,Capranzano Piera,Di Pino Luigi,Curatolo Giuseppina,Rodolico Margherita,Leggio Stefano,Blundo Anita,Tamburino Corrado,Monte Ines

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1007/s10545-013-9607-1

Reference29 articles.

1. Altarescu G, Moore DF, Pursley R et al (2001) Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke 32:1559–1562

2. Barbey F, Brakch N, Linhart A et al (2006a) Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 26:839–844

3. Barbey F, Brakch N, Linhart A et al (2006b) Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatr Suppl 95:63–68

4. Bollinger A, Fagrell B (1990) Clinical capillaroscopy. A guide to its use in clinical research and practice, Toronto. Hogrete & Huber, Toronto, pp 1–158

5. Boutouyrie P, Laurent S, Laloux B, Lidove O, Grunfeld JP, Germain DP (2002) Arterial remodelling in Fabry disease. Acta Paediatr 91(suppl 439):62–66

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac involvement in Anderson–Fabry disease. The role of advanced echocardiography;Frontiers in Cardiovascular Medicine;2024-09-02

2. Relationship between Capillaroscopic Architectural Patterns and Different Variant Subgroups in Fabry Disease: Analysis of Cases from a Multidisciplinary Center;Genes;2024-08-21

3. Inflammation, Oxidative Stress, and Endothelial Dysfunction in the Pathogenesis of Vascular Damage: Unraveling Novel Cardiovascular Risk Factors in Fabry Disease;International Journal of Molecular Sciences;2024-07-29

4. Biomarkers in anderson-Fabry disease: what should we use in the clinical practice?;Rare Disease and Orphan Drugs Journal;2024-04-25

5. Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease;Frontiers in Cardiovascular Medicine;2023-11-02